Yahoo Search Búsqueda en la Web

Entrar

Resultado de búsqueda

  1. www.gsk.com › en-gb › behind-the-science-magazine‘Global health progress is vital for millions of lives, but it...

    28 de may. de 2024 · Despite global efforts to change the course of high burden diseases like malaria and TB in lower income countries, progress has stalled. Here, GSK’s Chief Global Health Officer Thomas Breuer, MD, explains why, and what steps need to be taken to ensure more lives are saved from preventable infectious diseases. Let me paint you a ...

  2. Imágenes

    • Thomas Breuer - Gmeiner Verlag
    • Sieben Fragen an Thomas Breuer | Kriminetz
    • Thomas Breuer - Data Scientist - Deutsche Telekom AG | XING
    • Thomas Breuer will Parteichef werden: „Kaum jemand weiß, wofür die ...
    • Thomas Breuer – Religionspädagogischer Materialpool

    Ver todo

  3. www.globenewswire.com › news-release › 2024/05/07BioVersys Announces Expansion of Strategic Collaboration

    7 de may. de 2024 · Thomas Breuer, Chief Global Health Officer, GSK: "GSK is committed to changing the trajectory of tuberculosis and we’re excited to expand our partnership with BioVersys in the continued...

  4. www.ft.com › content › 0f19c56f-69ab-4898-9f7e-c6dcb7c34a95Malaria vaccine makers call for more orders to drive down costs

    21 de may. de 2024 · Thomas Breuer, chief global health officer at GSK, said despite the low numbers, not all the 3.5mn malaria vaccine doses it provided in 2023, in a pilot stage before the mass rollout, were...

  5. Videos

    Ver todo

  6. pharmasource.global › content › newsBioVersys and GSK Expand Collaboration to Accelerate TB Treatment

    9 de may. de 2024 · “GSK is committed to changing the trajectory of tuberculosis and we’re excited to expand our partnership with BioVersys,” said Thomas Breuer, Chief Global Health Officer, GSK. As part of the expanded collaboration, GSK will take an equity stake in BioVersys’ latest investment round.

  7. www.swissbiotech.org › listing › bioversys-announces-expansion-of-strategicBioVersys: More collaboration with GSK and series C round of CHF...

    7 de may. de 2024 · Thomas Breuer, Chief Global Health Officer, GSK: "GSK is committed to changing the trajectory of tuberculosis and we’re excited to expand our partnership with BioVersys in the continued development of alpibectir, a drug candidate with the potential to broaden the treatment options for TB.

  8. beam-alliance.eu › bioversys-announces-expansion-of-strategic-collaboration-withBioVersys Announces Expansion of Strategic Collaboration With GSK...

    7 de may. de 2024 · Thomas Breuer, Chief Global Health Officer, GSK: “GSK is committed to changing the trajectory of tuberculosis and we’re excited to expand our partnership with BioVersys in the continued development of alpibectir, a drug candidate with the potential to broaden the treatment options for TB.

  9. www.dk-online.de › lokales › ganderkeseeSo steht es um die Erweiterung von Edeka Boekhoff in Schierbrok |...

    13 de may. de 2024 · Von Thomas Breuer | 13.05.2024, 15:22 Uhr. „Wir drehen den Markt einmal.“ Wie sich Edeka vergrößern soll, zeigt der Entwurf des Architekten, den Otto Boekhoff in Händen hält. Foto: Thomas Breuer. Der Nahversorger Edeka Boekhoff spielt für Stenum und Schierbrok eine wichtige Rolle. Für die geplante Erweiterung entstehen derzeit die Parkplätze.